GOCOQ

GoHealth is a Medicare insurance marketplace in an active financial-distress spiral, and the numbers leave little room for interpretation. FY2025 revenue collapsed 54.7% to $362M — not from a demand shock but from management's own choice: the MD&A states they 'reduced our Medicare Advantage activities for the 2025 AEP season' and adopted 'a disciplined approach that prioritizes cash preservation.' The unit economics confirm the squeeze — Sales per Submission fell 14.5% to $668 while Direct Operating Cost per Submission rose 2.8% to $594, so the business is earning less on each sale even as carriers 'tighten plan economics by reducing or eliminating prefunded marketing spend' and designate preferred plans as non-commissionable. That is a structural industry headwind, not a one-year blip, and management expects it to 'persist into 2026.'

The balance sheet is where 'avoid' becomes non-negotiable. Long-term debt grew 42.2% to $637M while stockholders' equity cratered 84.3% to $37.9M and cash sits at just $32.9M against operating cash burn of -$122M. At that burn rate the cash cushion is roughly a quarter of a year of runway, and the $257M net loss (EPS -$20.17) drove accumulated deficit to -$680M. With a market cap of only $5.17M against $637M of debt, the enterprise is essentially all creditors; the equity is a deeply out-of-the-money option on a restructuring, and the 29.7% YoY rise in share count signals ongoing dilution to stay alive.